Related Experiment Videos
Hyperkalemic periodic paralysis associated with thyrotoxicosis
The Journal of the Association of Physicians of India
|April 1, 1993
Summary
Thyrotoxic periodic paralysis in a male patient presented with episodic motor weakness. Treatment with neomercazole and acetazolamide resolved symptoms, with continued relief on antithyroid medication alone.
Area of Science:
- Endocrinology
- Neurology
Background:
- Thyrotoxic periodic paralysis (TPP) is a rare endocrine-neuromuscular disorder.
- It primarily affects individuals of Asian descent but can occur in other populations.
Observation:
- A 32-year-old male presented with episodic pure motor weakness lasting 1.5 months.
- The patient was diagnosed with thyrotoxicosis (excess thyroid hormone).
Findings:
- A hyperkalemic challenge test provoked similar weakness and elevated serum potassium (6 meq/L).
- The patient responded to treatment with neomercazole (an antithyroid drug).
- Temporary addition of acetazolamide improved symptoms until the patient became euthyroid.
Implications:
- This case highlights the importance of considering TPP in patients with unexplained periodic weakness, especially if thyrotoxicosis is present.
- Effective management involves treating the underlying hyperthyroidism and may require adjunctive therapies like acetazolamide.
- Long-term euthyroid status achieved with antithyroid drugs alone led to sustained symptom resolution.